US-Made Research Peptides Hit 99%+ HPLC Purity Standard

Press Services
Today at 4:35pm UTC

PX1 Research Applies cGMP Quality Control and HPLC Purity Verification to US Peptide Manufacturing

Irvine, United States - August 10, 2026 / PX1 Research /

PX1 Research has expanded its domestic manufacturing framework to apply full US cGMP quality control standards across its entire catalog of research peptides, with HPLC purity verification results confirming 99% or greater purity on every batch produced. The move formalizes a multi-stage testing protocol that the company says is designed to meet the documentation and compliance expectations of academic institutions and independent research laboratories sourcing compounds for non-clinical study.

Seven-Stage Testing Across Every Production Batch

At the center of the expanded protocol is a seven-stage HPLC purity verification process applied to each production run before any compound is released. The process generates batch-specific Certificates of Analysis, commonly referred to as COAs, which accompany every order shipped. These documents provide researchers with traceable, lot-level purity data rather than generalized product specifications.

Compounds currently manufactured under this framework include Tirzepatide, Retatrutide, and BPC-157, among others available through PX1 Research's peptides catalog. Each of these compounds represents a category of research peptides that has drawn sustained interest from academic and institutional research programs examining metabolic, regenerative, and receptor-based mechanisms.

Domestic Production Aligned With cGMP Quality Control Standards

PX1 Research conducts its manufacturing operations within the United States, bringing production under domestic laboratory conditions that align with cGMP quality control requirements. This approach allows the company to maintain direct oversight of synthesis, handling, and testing at each stage, rather than relying on overseas contract manufacturing arrangements where documentation chains can be less transparent.

For research institutions, the significance of domestic production lies largely in consistency and auditability. When a laboratory requires documentation to support a study protocol or internal compliance review, batch-specific COAs generated under a defined cGMP quality control framework provide a verifiable paper trail. Each COA issued by PX1 Research ties directly to the specific lot number of the compound shipped, giving researchers the documentation specificity that generalized purity certificates cannot offer.

Research Peptides Supplied for Academic and Non-Clinical Use

PX1 Research positions its catalog strictly for research use, with compounds supplied to academic institutions, independent researchers, and licensed laboratories engaged in non-clinical study. The company does not market its research peptides for human consumption or therapeutic application, a distinction that aligns with federal guidelines governing the sale and distribution of compounds in this category.

The expansion of the compliance framework reflects growing scrutiny within the research supply sector over sourcing transparency. Laboratories sourcing research peptides have increasingly raised questions about whether purity claims from suppliers are supported by independent or in-house analytical testing. PX1 Research's HPLC purity verification system directly addresses that concern by making quantified, batch-level data available at the point of purchase.

Researchers and procurement contacts can reach the PX1 Research team directly at info@px1research.com or by phone at +1 (949) 739-5700 to request documentation or discuss compound availability for specific research applications.

About PX1 Research

PX1 Research is a US-based manufacturer and supplier of research peptides, producing compounds under cGMP quality control standards with HPLC purity verification conducted across seven testing stages. The company serves academic institutions and research laboratories with batch-specific Certificates of Analysis included with every order. Its catalog includes compounds such as Tirzepatide, Retatrutide, and BPC-157, available exclusively for non-clinical research use.

Learn more at PX1 Research

Contact Information:

PX1 Research

100 Main St, Suite 100
Irvine, CA 92614
United States

Cody Robert
+1 (949) 739-5700
https://px1research.com